↓ Skip to main content

Dove Medical Press

Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses

Overview of attention for article published in OncoTargets and therapy, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Readers on

mendeley
11 Mendeley
Title
Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses
Published in
OncoTargets and therapy, January 2013
DOI 10.2147/ott.s37916
Pubmed ID
Authors

Yoshiaki Andoh, Naohiko Makino, Mitsunori Yamakawa

Abstract

It is unclear whether there are any differences in the induction of cytotoxic T lymphocytes (CTL) and CD4(+)CD25(high) regulatory T-cells (Tregs) among dendritic cells (DCs) fused with different pancreatic carcinomas. The aim of this study was to compare the ability to induce cytotoxicity by human DCs fused with different human pancreatic carcinoma cell lines and to elucidate the causes of variable cytotoxicity among cell lines.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 9%
Taiwan 1 9%
Unknown 9 82%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 27%
Student > Bachelor 3 27%
Student > Ph. D. Student 2 18%
Student > Master 1 9%
Student > Doctoral Student 1 9%
Other 0 0%
Unknown 1 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 27%
Biochemistry, Genetics and Molecular Biology 2 18%
Medicine and Dentistry 2 18%
Nursing and Health Professions 1 9%
Physics and Astronomy 1 9%
Other 1 9%
Unknown 1 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2013.
All research outputs
#20,656,820
of 25,374,647 outputs
Outputs from OncoTargets and therapy
#1,597
of 3,016 outputs
Outputs of similar age
#228,824
of 289,004 outputs
Outputs of similar age from OncoTargets and therapy
#9
of 16 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,004 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.